GIM
VIVO
Greylin Investment Management’s Meridian Bioscience Inc VIVO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-47,585
| Closed | -$709K | – | 87 |
|
|
2018
Q3 | $709K | Sell |
47,585
-40,050
| -46% | -$597K | 0.15% | 47 |
|
|
2018
Q2 | $1.39M | Sell |
87,635
-1,525
| -2% | -$24.2K | 0.3% | 40 |
|
|
2018
Q1 | $1.27M | Buy |
89,160
+5,550
| +7% | +$78.8K | 0.27% | 38 |
|
|
2017
Q4 | $1.17M | Buy |
83,610
+11,275
| +16% | +$158K | 0.25% | 43 |
|
|
2017
Q3 | $1.03M | Buy |
72,335
+11,150
| +18% | +$159K | 0.24% | 43 |
|
|
2017
Q2 | $964K | Buy |
61,185
+10,050
| +20% | +$158K | 0.22% | 43 |
|
|
2017
Q1 | $706K | Sell |
51,135
-500
| -1% | -$6.9K | 0.16% | 48 |
|
|
2016
Q4 | $914K | Buy |
51,635
+19,825
| +62% | +$351K | 0.22% | 41 |
|
|
2016
Q3 | $614K | Buy |
31,810
+10,475
| +49% | +$202K | 0.15% | 51 |
|
|
2016
Q2 | $416K | Buy |
+21,335
| New | +$416K | 0.1% | 54 |
|
|
2016
Q1 | – | Sell |
-9,835
| Closed | -$202K | – | 78 |
|
|
2015
Q4 | $202K | Buy |
+9,835
| New | +$202K | 0.05% | 71 |
|